Streetbeat News

Analyst Ratings

KEY

KeyCorp (NYSE:KEY) is set to release its Q3 earnings on Oct. 17, with expected earnings of 15 cents per share, down from 29 cents a year ago. Revenue is projected at $1.27 billion, compared to $1.56 billion last year. Baird analyst David George downgraded KeyCorp from Outperform to Neutral, lowering the price target from $18 to $17. KeyCorp offers a 4.62% annual dividend yield, equating to 20.5 cents per share quarterly. To earn $500 monthly from dividends, an investor would need 7,317 shares, worth approximately $129,584.

Portfolio Pulse from Avi Kapoor

October 16, 2024 | 5:58 pm

ARMK

Goldman Sachs analyst Lizzie Dove has maintained a Buy rating on Aramark (NYSE:ARMK) and raised the price target from $38 to $41.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 5:58 pm

BWFG

Keefe, Bruyette & Woods analyst Christopher O'Connell has reiterated an 'Outperform' rating for Bankwell Financial Group (NASDAQ:BWFG) and maintained a price target of $34.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 5:55 pm

JBHT

BMO Capital has reiterated its 'Outperform' rating for JB Hunt Transport Services, maintaining a price target of $195.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 5:52 pm

COTY

DA Davidson analyst Linda Bolton Weiser maintains a Buy rating on Coty (NYSE:COTY) but lowers the price target from $17 to $14.5.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 5:52 pm

WOLF

Wolfspeed shares rose after Morgan Stanley maintained an Equal-Weight rating and increased its price target from $10 to $15.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 5:52 pm

EA

BMO Capital analyst Brian Pitz has reiterated an 'Outperform' rating for Electronic Arts (NASDAQ:EA) and maintained a price target of $154.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 5:50 pm

LEVI

Telsey Advisory Group has reiterated its 'Outperform' rating for Levi Strauss, maintaining a price target of $26.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 5:49 pm

DKNG

BMO Capital analyst Brian Pitz has reiterated an Outperform rating for DraftKings, maintaining a price target of $48.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 5:48 pm

URGN

EF Hutton analyst Jason Kolbert has reiterated a Buy rating for UroGen Pharma (NASDAQ:URGN) and maintained a price target of $25.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 5:45 pm